The Aesthetic Guide is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Valeant secures rights to market Refissa

Article-Valeant secures rights to market Refissa

Aliso Viejo, Calif. — Valeant Pharmaceuticals International, based here, has entered into an agreement with Spear Pharmaceuticals, Fort Myers, Fla., for the rights to commercialize Refissa (tretinoin cream, USP [emollient] 0.05 percent), a prescription topical cream used to treat fine wrinkles and irregular pigmentation due to sun damage, PR Newswire-FirstCall reports.

Valeant will pay Spear $12 million up front, and the companies will share net profits. Valeant will book sales and use its dermatology sales force to promote Refissa to dermatologists nationwide.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.